NCT00580983View on ClinicalTrials.gov

Optimized Intensity Modulated Irradiation for Head and Neck Cancer

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Head and Neck Cancer
Interventions
RADIATION

IMRT

DRUG

Paclitaxel

DRUG

Carboplatin

DRUG

Cisplatin

DRUG

5-Fluorouracil

Trial Locations (1)

48109-5010

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00580983 - Optimized Intensity Modulated Irradiation for Head and Neck Cancer | Biotech Hunter | Biotech Hunter